Latest Breaking News On - Prnewswire evox therapeutics ltd - Page 1 : comparemela.com

Share this article Share this article OXFORD, England, Feb. 18, 2021 /PRNewswire/ Evox Therapeutics Ltd ( Evox or the Company ), a leading exosome therapeutics company, today announces that it has raised £69.2 million ($95.4 million) in a Series C financing round. The financing was significantly oversubscribed with high demand from both existing and new investors. The Series C financing was led by Redmile Group who were joined by new investors OrbiMed and Invus. In addition to Redmile, all existing Series B investors reinvested, including major investors Oxford Sciences Innovation (OSI), GV (formerly Google Ventures) and Cowen Healthcare Investments. Eli Lilly, also converted a $10 million convertible note, that formed part of our 2020 collaboration agreement with them, into equity as part of this round.

Chau khuongEli lillyOxford sciences innovationRedmile groupPrnewswire evox therapeutics ltdTherapeutics ltdGoogle venturesCowen healthcareAntonin de fougerollesChief executive officerEvox therapeuticsHealth care amp hospitalsMedical pharmaceuticalsBanking amp financial servicesClinical trials amp medical discoveriesFinancing agreements